Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Apalutamide","url":"https:\/\/www.ortaakarsu.net\/?page_id=12325","facts":[{"label":"Active ingredient \/ generic name","value":"apalutamide"},{"label":"ATC code","value":"L02BB05"},{"label":"Administration route","value":"Oral"}]},{"title":"Macitentan","url":"https:\/\/www.ortaakarsu.net\/?page_id=12383","facts":[{"label":"Active ingredient \/ generic name","value":"macitentan"},{"label":"ATC code","value":"C02KX04"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"EMA product-information update 23\/04\/2026; 4.4 Strong CYP3A4 inducers; 4.5 Strong CYP3A4 inducers"}],"sources":[{"label":"Opsumit \u2014 EMA product information","url":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/opsumit-epar-product-information_en.pdf"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:28850","available":true}}